In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Martin McLaughlin, former Head of Launch and Business Excellence at Takeda, to share the frameworks and lessons that help pharma organizations align people, processes, performance, and technology for success.What You’ll Learn:How to break down the launch silo mentality plaguing 77% of pharma organizationsMartin’s four-pillar launch playbookWhy Launch Performance Indicators (LPIs) matter more than traditional KPIsHow to operationalize scenario planning and pivot without losing momentumWhere the real pharma AI wins actually happenMartin McLaughlin is the former Head of Launch and Business Excellence at Takeda, bringing 25 years of industry experience spanning clinical development, sales, marketing, and launch strategy. With a background in science and industrial microbiology, he has built and led high-performing cross-functional teams through complex product launches across multiple therapeutic areas, including rare disease and competitive markets. Currently, Martin is Chief of Staff and Head of Commercial Excellence at Teva Pharmaceuticals.Episode Highlights[00:00] Introduction[01:30] The Journey to Launch Excellence[04:02] The Four-Pillar Playbook[06:03] Building True Cross-Functional Teams[07:22] Launch Performance Indicators (LPIs)[08:46] The Six-Month Window That Defines Success[10:17] When the Market Fights Back[12:38] Institutional Memory for Global Teams[16:37] Where Tech Fits in Pharma Launches[20:02] Change Management and Building Capacity[25:00] Leading with Trust and EQ[26:06] Final Advice for Pharma LeadersEpisode Resources:Martin McLaughlin on LinkedInTeva Pharmaceuticals WebsiteTakeda WebsiteJonathan Kaskey on LinkedInXSUNT Corporation WebsiteOr join the Pharma Sessions Substack:www.pharmasessions.substack.com